Sheryl Dai’s practice focuses on venture capital, private equity and mergers and acquisitions matters. She represents a number of renowned venture capital funds in connection with their investment in China and U.S. based biotech, pharmaceutical and IT companies at various stages. She also represents institutional investors in structuring and negotiating their investments in private equity funds.
Download full bio